Who Owns Replimune Group Stock?
NASDAQ: REPLHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 105.76%
- Institutions (% of float)
- 107.53%
- Held by insiders
- 1.65%
- Institutional holders
- 253
- Institutions 98.4%
- Insiders 1.6%
- Public and other 0.0%
Who owns Replimune Group stock?
Institutional investors own about 105.8% of Replimune Group's shares, spread across 253 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.65% of REPL.
The largest institutional holders are Baker Bros. Advisors, LP (11.78%), Blackrock Inc. (9.55%) and RTW Investments LP (7.90%). Together, the top 10 institutions control 61.6% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their REPL positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of REPL
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Baker Bros. Advisors, LP | 11.05M | 11.78% | 0.0% |
| Blackrock Inc. | 8.96M | 9.55% | +43.6% |
| RTW Investments LP | 7.41M | 7.90% | +0.7% |
| Ridgeback Capital Investments L.P. | 7.31M | 7.79% | +100.0% |
| Goldman Sachs Group Inc | 4.54M | 4.84% | +99.4% |
| State Street Corporation | 4.44M | 4.73% | +17.4% |
| Montanova Capital LLC | 4.39M | 4.68% | +4.0% |
| Boxer Capital Management, LLC | 3.98M | 4.25% | +239.0% |
| Vanguard Capital Management LLC | 2.90M | 3.09% | +5.0% |
| FCPM III Services B.V. | 2.81M | 2.99% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of REPL
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.90M | 3.09% |
| iShares Trust-iShares Russell 2000 ETF | 2.04M | 2.18% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.97M | 2.10% |
| BlackRock Funds-BlackRock Advantage Small Cap Core Fund | 870.06K | 0.93% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 865.97K | 0.92% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 854.09K | 0.91% |
| iShares Trust-iShares Russell 2000 Value ETF | 739.30K | 0.79% |
| T. Rowe Price New Horizons Fund, Inc. | 718.80K | 0.77% |
| iShares Trust-iShares Biotechnology ETF | 654.56K | 0.70% |
| FINANCIAL INVESTORS TRUST-Emerald Growth Fund | 624.30K | 0.67% |
Frequently asked questions
Who is the largest shareholder of Replimune Group?
Baker Bros. Advisors, LP is the largest institutional shareholder of REPL, owning 11.78% of shares outstanding (11.05M shares) as of its latest 13F filing.
What percentage of Replimune Group is owned by institutions?
Institutions own about 105.8% of REPL shares and 107.5% of the public float.
How much of Replimune Group do insiders own?
Insiders, such as officers and directors, own about 1.65% of REPL shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.